Skip to content

Sector benchmark

Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.

Sector benchmark

ExMediKA

BE 0785.643.679
NACE 74.999, Other professional, scientific and technical activities
NACE division 74, Other professional, scientific and technical activities all sizesfiscal years 2023 to 20253,621 to 4,192 sector peers per ratio

Summary

fiscal year 2025

ExMediKA does better than half of its sector on 8 of the 8 ratios compared.

most favourable quarter above the median below the median least favourable quarter
Strongest points
  • Working-capital ratiobetter than 83%
  • Interest coveragebetter than 78%
  • Return on assetsbetter than 76%
Points to watch

No ratio below the sector median.

    Solvency and debt

    How soundly the company is financed.
    Solvency
    72.1%▲2025

    Solvency is above 72% of 4,184 sector peers: more favourable than the median.

    Position against the sector improving since 2023.

    202320242025
    Debt to equity
    0.39▼2025

    Debt to equity is below 60% of 4,124 sector peers: more favourable than the median.

    Position against the sector improving since 2023.

    202320242025
    Interest coverage
    88.80▼2025

    Interest coverage is above 78% of 3,839 sector peers: in the most favourable quarter.

    Position against the sector weakening since 2023.

    202320242025

    Liquidity

    Whether it can pay its short-term bills.
    Current ratio
    3.75▲2025

    The current ratio is above 74% of 4,152 sector peers: more favourable than the median.

    Position against the sector improving since 2023.

    202320242025
    Quick ratio
    3.73▲2025

    The quick ratio is above 75% of 4,152 sector peers: in the most favourable quarter.

    Position against the sector improving since 2023.

    202320242025
    Working-capital ratio
    73.3%▲2025

    The working-capital ratio is above 83% of 4,179 sector peers: in the most favourable quarter.

    Position against the sector improving since 2023.

    202320242025

    Profitability

    What the company earns on its assets and its sales.
    Return on equity
    34.4%▼2025

    Return on equity is above 65% of 3,621 sector peers: more favourable than the median.

    Position against the sector weakening since 2023.

    202320242025
    Return on assets
    24.8%▼2025

    Return on assets is above 76% of 4,192 sector peers: in the most favourable quarter.

    Position against the sector weakening since 2023.

    202320242025

    Not computable

    Long-term debt ratio, Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.

    Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 27 September 2026 via checked.be.